Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.

× No keyword cloud information.

17 in total

1. Electrophoretic studies of the conversion products of serum beta-1C-globulin.

Authors: C B Laurell; B Lundh
Journal: Immunology Date: 1967-03 Impact factor: 7.397

2. A classification of chronic hepatitis.

Authors: J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal: Lancet Date: 1968-09-14 Impact factor: 79.321

3. Immunofixation electrophoresis: a technique for the study of protein polymorphism.

Authors: C A Alper; A M Johnson
Journal: Vox Sang Date: 1969-11 Impact factor: 2.144

4. Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors: G Mancini; A O Carbonara; J F Heremans
Journal: Immunochemistry Date: 1965-09

5. High voltage agarose gel electrophoresis in the study of C 3 polymorphism.

Authors: P Teisberg
Journal: Vox Sang Date: 1970-07 Impact factor: 2.144

6. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies.

Authors: E Alpert; K J Isselbacher; P H Schur
Journal: N Engl J Med Date: 1971-07-22 Impact factor: 91.245

7. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.

Authors: C A Alper; N Abramson; R B Johnston; J H Jandl; F S Rosen
Journal: J Clin Invest Date: 1970-11 Impact factor: 14.808

8. Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.

Authors: F J Dudley; R A Fox; S Sherlock
Journal: Lancet Date: 1971-07-03 Impact factor: 79.321

9. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.

Authors: L D Petz; D J Fink; E A Letsky; H H Fudenberg; J Müller-Eberhard
Journal: J Clin Invest Date: 1969-11 Impact factor: 14.808

10. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

Authors: C A Alper; F S Rosen
Journal: J Clin Invest Date: 1967-12 Impact factor: 14.808

15 in total

1. Editorial: Complement activation and disease.

Authors:
Journal: Br Med J Date: 1976-02-21

2. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors: L H Perrin; P H Lambert; P A Miescher
Journal: J Clin Invest Date: 1975-07 Impact factor: 14.808

3. Acute hepatitis: significance of changes in complement components.

Authors: J A Charlesworth; S Lawrence; P A Worsdall; L P Roy; C R Boughton
Journal: Clin Exp Immunol Date: 1977-06 Impact factor: 4.330

4. Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years.

Authors: R C Gupta; E R Dickson; F C McDuffie; A H Baggenstoss
Journal: Clin Exp Immunol Date: 1978-10 Impact factor: 4.330

Review 5. Methods to detect and quantitate complement activation.

Authors: N R Cooper; G R Nemerow; J T Mayes
Journal: Springer Semin Immunopathol Date: 1983

6. Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.

Authors: E R Richens; C M Thorp; P W Bland; N D Hall
Journal: Dig Dis Sci Date: 1982-02 Impact factor: 3.199

Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.